(1) Food-schedule intermittency can induce several sorts of chronic, excessive behaviors, including oral drug overindulgence. Under these schedule-induction conditions, animals will be allowed a concurrent choice to work for either a drug solution (cocaine, caffeine or nicotine) or water to investigate how both pharmacological and nonpharmacological factors come to contribute to the selection and maintenance of substance abuse. (2) The conditions under which selective acquisition of oral drug abuse occurs (intermittency of a crucial reinforcer, facilitation by conditioned reinforcers) may model the crucial participation of nonpharmacological factors operative when humans acquire substance abuse (lack of rewarding alternatives, facilitation by social reinforcers). The parameters of abuse induction will undergo analysis. (3) Gateway agents affecting acquisition, and agonist and antagonist drugs affecting the drug abuse, will be assessed. (4) The behavioral consequences of cocaine, caffeine and nicotine, both when injected and when taken by oral overindulgence will be measured by a variety of behavioral techniques (e.g., locomotor activities, fine-motor task performance, timing capacities) and (5) related quantitatively in parallel studies to serum drug and metabolite pharmacokinetics. (6) The effects of simultaneous exposure to two-drug combinations will evaluate possible synergistic or ameliorative outcomes, particularly when a licit agent is taken along with cocaine. (7) The simultaneous coabuse of ethanol and cocaine is frequent for cocaine abusers, and the possible contributary action of the active metabolite cocaethylene will be evaluated behaviorally. (8) The effect of both chronic schedule-induced vehicle and cocaine drinking on brain regional monoamines and their metabolites will be investigated. (9) A pharmacologic analysis of caffeine's action will be tried using adenosine agonist and antagonist agents with 1 or 2 behavioral techniques.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA005305-06
Application #
3211562
Study Section
Drug Abuse Clinical and Behavioral Research Review Committee (DACB)
Project Start
1987-09-30
Project End
1997-11-30
Budget Start
1992-12-01
Budget End
1993-11-30
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Rutgers University
Department
Type
Schools of Arts and Sciences
DUNS #
038633251
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Lau, Chyan E; Sun, Lei (2002) The pharmacokinetic determinants of the frequency and pattern of intravenous cocaine self-administration in rats by pharmacokinetic modeling. Drug Metab Dispos 30:254-61
Sun, L; Lau, C E (2001) Simultaneous pharmacokinetic modeling of cocaine and its metabolites, norcocaine and benzoylecgonine, after intravenous and oral administration in rats. Drug Metab Dispos 29:1183-9
Sun, L; Lau, C E (2001) Arteriovenous serum cocaine concentration difference after intravenous bolus injection and constant-rate infusions: relation to pharmacodynamic estimates in rats. Eur J Pharm Sci 14:261-9
Wang, Q; Simpao, A; Sun, L et al. (2001) Contribution of the active metabolite, norcocaine, to cocaine's effects after intravenous and oral administration in rats: pharmacodynamics. Psychopharmacology (Berl) 153:341-52
Falk, J L; D'Mello, K; Lau, C E (2001) Two procedures establishing preference for oral cocaine and lidocaine solutions which do not use an associative history with a reinforcer. Behav Pharmacol 12:117-23
Lau, C E; Sun, L; Wang, Q et al. (2000) Oral cocaine pharmacokinetics and pharmacodynamics in a cumulative-dose regimen: pharmacokinetic-pharmacodynamic modeling of concurrent operant and spontaneous behavior within an operant context. J Pharmacol Exp Ther 295:634-43
Sun, L; Hall, G; Lau, C E (2000) High-performance liquid chromatographic determination of cocaine and its metabolites in serum microsamples with fluorimetric detection and its application to pharmacokinetics in rats. J Chromatogr B Biomed Sci Appl 745:315-23
Falk, J L; Yosef, E; Schwartz, A et al. (1999) Establishing oral preference for quinine, phencyclidine and caffeine solutions in rats. Behav Pharmacol 10:27-38
Ma, F; Falk, J L; Lau, C E (1999) Within-subject variability in cocaine pharmacokinetics and pharmacodynamics after intraperitoneal compared with intravenous cocaine administration. Exp Clin Psychopharmacol 7:3-12
Falk, J L; Yosef, E; Kuo, C et al. (1999) Establishing preference for lidocaine solution to water: comparison between a fading and an abrupt-removal procedure for withdrawing a compound vehicle. Behav Pharmacol 10:803-8

Showing the most recent 10 out of 43 publications